A comparative study of real hospital costs and INA-CBG rates for stroke in Indonesia
DOI:
https://doi.org/10.46542/pe.2024.243.166172Keywords:
Case-based group, Direct medical cost, Health insurance programme, Real cost, StrokeAbstract
Background: The claim payment method in JKN program uses the prospective Indonesian Case Base Groups (INA-CBG) method, in which the rate has been determined before health services are provided based on the diagnosis code group. This potentially causes a discrepancy in the costs incurred by health facilities.
Objective: This systematic review aimed to provide an overview of the comparison of actual hospital costs with the INA-CBG rates of the JKN program for inpatient stroke.
Method: The collection method used a PRISMA flowchart on several databases. This systematic review is a comparative study comparing the significance of the average actual direct medical costs with the INA-CBG rates.
Result: Cost differences on intracerebral haemorrhage (I619) and unspecified stroke diagnosis (I64) consistently give a negative difference around IDR 110,659 – IDR 8,184,007/patient/episode. Medicine and medical equipment are the most significant components of stroke treatments. Factors that significantly influence direct medical costs are the length of stay (LOS), class of JKN, and age.
Conclusion: Cost differences can be influenced by several factors that can affect the direct medical costs of hospitals. The factor that has the most influence on the amount of direct medical cost is LOS.
References
BPJS, K. R. I. (2014). The health social assurance administrator info: Changes in INA-CBGs tariffs make health costs more effective. Central Jakarta: The health social assurance administrator of Indonesia.
BPJS, K. R. I. (2021). The Health social assurance administrator info: Expensive catastrophic illnesses are still guaranteed by the JKN-KIS Program. Central Jakarta: The Health Social Assurance Administrator of Indonesia.
Chetrine, H., Nugraheni, D. A., Rugiarti, N. D., & Tetuko, A. (2022). Comparison of Indonesian-case based group rates for inpatient ischemic stroke disease in government hospitals. Pharmacy Medical Journal, 5(1), 1‒6. https://doi.org/10.35799/pmj.v5i1.41193
Feigin, V. L., Brainin, M., Norrving, B., Martins, S., Sacco, R. L., Hacke, W., Fisher, M., Pandian, J., & Lindsay, P. (2022). World Stroke Organisation (WSO): Global stroke fact sheet 2022. International Journal of stroke, 17(1), 1‒29. https://doi.org/10.1177/17474930211065917
Hadning, I., Fathurrohmah, F., Ridwan, M., Rahajeng, B., Utami, P., & Cahyaningsih, I. (2020). Cost analysis of Indonesia case based groups (INA-CBGs) tariff for stroke patients. Journal of management and pharmacy practice, 10(2), 137‒144. https://doi.org/10.22146/jmpf.46720
Hadning, I., Ikawati, Z., & Andayani, T. M. (2015). Stroke Treatment cost analysis for consideration on health cost Determination Using INA-CBGs at Jogja Hospital. International Journal of Public Health Science, 4(4), 288‒293. http://doi.org/10.11591/ijphs.v4i4.4748
Hassard, J., Teoh, K. R. H., Visockaite, G., Dewe, P., & Cox, T. (2018). The cost of work-related stress to society: A systematic review. Journal of occupational health Psychology, 23(1), 1‒17. https://doi.org/10.1037/ocp0000069
Huang, Y.-C., Hu, C.-J., Lee, T.-H., Yang, J.-T., Weng, H.-H., Lin, L. C., & Lai, S.-L. (2013). The impact factors on the cost and length of stay among acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 22(7), e152‒e158. https://doi.org/https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.10.014
Kemenkes, R. I. (2014). Regulation of the Minister of Health of the Republic of Indonesia No. 28 of 2014 concerning Guidelines for Implementing the National Health Insurance Program. Jakarta: Ministry of Health of the Republic of Indonesia
Kemenkes, R. I. (2016a). The National Health Insurance Program of Indonesia (JKN) Guidebook for Key Populations. Jakarta: Ministry of Health of the Republic of Indonesia.
Kemenkes, R. I. (2016b). Regulation of the Minister of Health of the Republic of Indonesia No. 76 of 2016 concerning Guidelines for Indonesia Case Based Groups (INA-CBG) in the Implementation of National Health Insurance. Jakarta: Ministry of Health of the Republic of Indonesia.
Kemenkes, R. I. (2022). Indonesia Health Profile in 2021. Jakarta: Ministry of Health of the Republic of Indonesia
Kemenkes, R. I. (2023). Regulation of the Minister of Health of the Republic of Indonesia No. 3 of 2023 concerning Health Service Tariff Standards in the Implementation of Health Insurance Programs. Jakarta: Ministry of Health of the Republic of Indonesia
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology, 62(10), e1‒34. https://doi.org/10.1016/j.jclinepi.2009.06.006
Mazidah, Z., Yasin, N. M., & Kristina, S. A. (2019). Analysis of stroke costs for National Health Insurance patients at Banyuwangi Blambangan Hospital. Journal of Pharmaceutical Management and Services, 9(2), 76‒87. https://doi.org/10.22146/jmpf.41984
Mulyanti, Saputra, I., Syukri, M., Nurjannah, & Lestari, N. D. (2020). Comparison analysis of real costs with Ina-CBG rate's ischemic stroke disease in installations in Regional Public Hospitals X in Banda Aceh 2019. Budapest International Research and Critics Institute-Journal (BIRCI-Journal), 3(3), 2479‒2493.
Munawaroh, S., Sulistiadi, W., & Rachmad, R. (2019). Difference between INA-CBG's rates and real hospital rates for BPJS patients with class I inpatient ischemic stroke cases at PON Hospital in 2018. Indonesian Journal of Hospital Management and Administration, 3(2), 155‒164
Muslimah M., Andayani, T. M., Pinzon, R., & Endarti, D. (2017). Comparison of real costs against INA-CBG's ischemic stroke rates at Bethesda Hospital Yogyakarta. Journal of Pharmaceutical Management and Services, 7(2). https://doi.org/10.22146/jmpf.30289
Negara, S. B. S. M. K., Octavia, D. R., & Utami, P. R. (2021). The comparison of the actual cost to case-mix of type 2 diabetes mellitus inpatient in Pandan Arang Boyolali hospital. Pharmacy Education, 21(2), p. 269‒274. https://doi.org/10.46542/pe.2021.212.269274
OECD. (2023). Inflation (CPI) (indicator). Retrieved 8 August 2023 from https://data.oecd.org/price/inflation-cpi.htm#indicator-chart
Patty, Y. F. P. P., Nita, Y., & Libriansyah. (2022). Cost of illness analysis of diabetes mellitus with complications in one hospital in Surabaya. Pharmacy Education, 22(2), 254‒258. https://doi.org/10.46542/pe.2022.222.254258
Rochmah, T. N., Rahmawati, I. T., Dahlui, M., Budiarto, W., & Bilqis, N. (2021). Economic burden of stroke disease: A Systematic Review. International Journal of Environmental Research and Public Health, 18(14), 7552. https://doi.org/10.3390/ijerph18147552
Sofan, A., & Syamsudin, S. (2021). Analysis of treatment costs for inpatient ischemic stroke patients at Dr. Dradjat Prawira Hospital, Serang State. Syntax Literate: Indonesian Scientific Journal, 6(3), 1075‒1090. https://doi.org/10.36418/syntax-literate.v6i3.2374
Strilciuc, S., Grad, D. A., Radu, C., Chira, D., Stan, A., Ungureanu, M., Gheorghe, A., & Muresanu, F. D. (2021). The economic burden of stroke: a systematic review of cost of illness studies. J Med Life, 14(5), 606‒619. https://doi.org/10.25122/jml-2021-0361
Tandah, M. R., Mukaddas, A., Angriani, D., & Mangoting, G. N. A. (2021). Cost evaluation of stroke therapy compared to INA-CBGs on inpatients at Anutapura Hospital. The Indonesian Journal of Public Health, 12(6), 285‒296. https://doi.org/10.20473/ijph.v16i2.2021.285-296
Wirastuti, K., Sulistyaningrum, I. H., Cahyono, E. B., Santoso, A., & Miftahudin, Z. (2019). Comparison of real costs with Ina-Cbg's stroke rates in the era of National Health Insurance at Sultan Agung Islamic Hospital. Ibnu Sina Scientific Journal, 4(1).
